Skip to main content
Premium Trial:

Request an Annual Quote

Singulex's Troponin Assay Gets CE Marking

NEW YORK (GenomeWeb) – Singulex on Thursday said that it has received CE marking for its Sgx Clarity cTnl assay for the quantitative measurement of troponin.

The test is the first offered for the Sgx Clarity system, a fully automated in vitro diagnostic platform leveraging single-molecule counting technology, and measures troponin at levels "far lower than existing technologies," according to Singulex. The assay is indicated for use in conjunction with clinical evaluation for ruling out cardiac ischemia in patients suspected of having coronary artery disease.

Singulex President and CEO Guido Baechler said that the firm is working closely with European researcher sites "to develop best practices and training for optimal introduction and utility" for the test.

Singulex received CE marking for the Sgx Clarity system in April. It said that it will submit data for clearance by the US Food and Drug Administration for the system and the troponin assay, and anticipates receiving clearance in 2018. 

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.